Urinary TIMP2 and IGFBP7 Identifies High Risk Patients of Short-Term Progression from Mild and Moderate to Severe Acute Kidney Injury during Septic Shock: A Prospective Cohort Study.
Julien MaizelDelphine DaubinLy Van VongDimitri Titeca BeauportMorgane WetzsteinLoay KontarMichel SlamaKada KloucheChristophe VinsonneauPublished in: Disease markers (2019)
The urinary TIMP2∗IGFBP7 concentration and the urine output at the early phase of septic shock are independent factors to identify the population at high risk of progression from mild and moderate to severe AKI over the next 24 but not 72 hours. A TIMP2∗IGFBP7 concentration > 2.0 (ng/ml)2/1,000 quadruples the risk of KDIGO 3 AKI within 24 hours. This trial is registered with (NCT03547414).
Keyphrases
- septic shock
- acute kidney injury
- cardiac surgery
- end stage renal disease
- ejection fraction
- high intensity
- early onset
- newly diagnosed
- chronic kidney disease
- clinical trial
- peritoneal dialysis
- prognostic factors
- study protocol
- genome wide
- phase iii
- gene expression
- phase ii
- patient reported outcomes
- open label
- drug induced